MedPath

MRS AD Study.

Completed
Conditions
Alzheimer¡¯s Disease
Registration Number
NL-OMON23328
Lead Sponsor
Danone Research ¨C Centre for Specialised Nutrition
Brief Summary

Results published in 'Alzheimer's Research & Therapy', website: https://doi.org/10.1186/s13195-017-0286-2

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Main inclusion criteria:

1. Diagnosis of probable or possible AD with evidence of the pathophysiological process according to the recently revised criteria;

Exclusion Criteria

Main exclusion criteria:

1. Diagnosis of significant neurological and/or psychiatric disease other than AD;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. The main 31P-MRS outcome parameters are the total level of Phosphomonoesters (PME), total level of Phosphodiesters (PDE), and the ratio between PME and PDE;<br /><br>2. 1H-MRS outcome parameters: Absolute and relative brain tissue levels of several metabolites.
Secondary Outcome Measures
NameTimeMethod
Blood parameters: Nutritional blood parameters.
© Copyright 2025. All Rights Reserved by MedPath